Burkholderia mallei (Glanders) Attack

Disaster Medicine

Volumn , Issue , 2006, Pages 647-649

  Graber, Mark A ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 50449092988     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-03253-7.50121-7     Document Type: Chapter

References (14)

1. U.S. Army Medical Research Institute of Infectious Disease. USAMRIID's Medical Management of Biological Casualties Handbook. 5th ed. Fort Detrick, Md: August 2004. Available at:. http://www.usamriid.army.mil/education/bluebook.htm.
2. Anonymous. Laboratory-acquired human glanders-Maryland, May 2000. MMWR 2000, 49:532-535.
3. Lever MS, Nelson M, Ireland PI, et al. Experimental aerogenic Burkholderia mallei (glanders) infection in the BALB/c mouse. J Med Microbiol. 2003, 52(Pt 12):1109-1115.
4. Woods DE The use of animal infection models to study the patho-genesis of melioidosis and glanders. Trends Microbiol. 2002, 10:483-484.
5. Utrup LJ, Frey AH Fate of bioterrorism-relevant viruses and bacteria, including spores, aerosolized into an indoor air environment. Exp Biol Med. 2004, 229:345-350.
6. Rega PP, Batts D, Hall AH, et al. Glanders and melioidosis. April 6, 2005. Available at:. http://www.emedicine.com/emerg/topic884.htm.
7. Srinivasan A, Kraus CN, DeShazer D, et al. Glanders in a military research microbiologist. N Engl J Med. 2001, 345:256-258.
8. Gee JE, Sacchi CT, Glass MB, et al. Use of 16S rRNA gene sequencing for rapid identification and differentiation of Burkholderia pseudomallei and B. mallei. J Clin Microbiol. 2003, 41:4647-4654.
9. PATHPORT. Pathlnfo pathogen information. Virginia Bioinformatics Institute. Available at:. http://staff.vbi.vt.edu/pathport/pathinfo/.
10. Blancou J Early methods for the surveillance and control of Glanders in Europe. Rev Sci Tech. 1994, 13:545-557.
11. The European Agency for the Evaluation of Medicinal Products, EMEA/CPMP Guidance Document On The Use of Medicinal Products for Treatment and Prophylaxis of Biological Agents that might be used as Weapons of Bioterrorism, 2002. Available at:. http://www.emea.eu.int/pdfs/human/bioterror/404801.pdf.
12. Heine HS, England MJ, Waag DM, et al. In vitro antibiotic susceptibilities of Burkholderia mallei (causative agent of glanders) determined by broth microdilution and E-test. Antimicrob Agents Chemother. 2001, 45:2119-2121.
13. Johns Hopkins Division of Infectious Disease. Johns Hopkins' Antibiotic Guide 2004. Available at:. http://hopkins-abxguide.org.
14. Russell P, Eley SM, Ellis J, et al. Comparison of efficacy of ciprofloxacin and doxycycline against experimental melioidosis and glanders. J Antimicrob Chemother. 2000, 45:813-818.